Lucentis is a prescription drug for the treatment of patients with wet age-related macular degeneration and macular edema.

FORBES: Move up http://i.forbesimg.com t Move down

By the end of the study, the researchers showed that 9.3% of patients taking aspirin developed wet age-related macular degeneration (AMD) compared with 3.7% of patients who did not take aspirin.

BBC: Long-term aspirin 'blindness link'

Two breakthrough drugs from Genentech (nyse: DNA - news - people ) offer hope for patients with the more severe "wet" form of age-related macular degeneration, or AMD.

FORBES: Banishing Blind Spots

It is now focused on seeking treatments for major eye diseases, including Wet AMD, or age-related macular degeneration.

FORBES: Teva Chairman Continues To Seek Undervalued Biopharmaceuticals

Two breakthrough drugs from Genentech offer hope for patients with the more severe "wet" form (which is more common in Asia than in the U.S.) of age-related macular degeneration, or AMD.

FORBES: Magazine Article

Two breakthrough drugs from Genentech (nyse: DNA - news - people ) offer hope for patients with the more severe "wet" form (which is more common in Asia than in the U.S.) of age-related macular degeneration, or AMD.

FORBES: Banishing Blind Spots